IA
KURA icon

IFP Advisors’s Kura Oncology KURA Stock Holding History

IFP Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.9K Buy
2,542
+1,467
+136% +$13.8K ﹤0.01% 2754
2026
Q1 		$8.74K Sell
1,075
-1,323
-55% -$11.4K ﹤0.01% 3216
2025
Q4 		$24.9K Buy
2,398
+1,284
+115% +$13.5K ﹤0.01% 2607
2025
Q3 		$9.86K Buy
1,114
+875
+366% +$6.24K ﹤0.01% 2912
2025
Q2 		$1.38K Buy
+239
New +$1.46K ﹤0.01% 4072
2025
Q1 		– Sell
-9
Closed -$78 – 4501
2024
Q4 		$78 Buy
+9
New +$130 ﹤0.01% 4120
2020
Q4 		– Sell
-2,628
Closed -$92.3K – 3026
2020
Q3 		$81K Buy
+2,628
New +$58K ﹤0.01% 1088
2019
Q1 		– Sell
-14
Closed – – 2928
2018
Q4 		$0 Hold
14
– – ﹤0.01% 3717
2018
Q3 		$0 Buy
+14
New +$268 ﹤0.01% 3925

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

IFP Advisors's KURA Position: Q2 2026 in Review

IFP Advisors increased its Kura Oncology (KURA) stake by 136% in Q2 2026, buying an estimated $13.8K and bringing the position to 2,542 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2754.

IFP Advisors first reported a position in KURA in Q3 2018 and has held it in 9 quarters since. The position peaked at $81K in Q3 2020. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • IFP Advisors held 2,542 shares of Kura Oncology worth $27.9K as of Q2 2026.
  • IFP Advisors bought 1,467 Kura Oncology shares in Q2 2026, an estimated $13.8K.
  • Kura Oncology made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2754 holding.
  • IFP Advisors first reported a position in Kura Oncology in Q3 2018 and has held it in 9 quarters since.
  • IFP Advisors's Kura Oncology position peaked at $81K in Q3 2020.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.